510(k) Report

510(k) · Cleared

Cleared

INVU by Nuvo

K210025510(k) TraditionalCleared May 28, 2021144-day reviewClass II21 CFR 884.2730

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nuvo- Group, Ltd. · LQK Home Uterine Activity Monitor

Cleared on May 28, 2021 as substantially equivalent to K143114 (Airstrip Technologies, Inc., 2015) after a 144-day review. Its family tree reaches back 3 generations to 2001. 1 later device descends from it.

Decided
May 28, 2021
Review
144 days
Class
Class II
Product code
LQK
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K002548 (2001). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK002548 Fetal AssistHuntleigh Diagnostics, Ltd. · 2001
  2. 2 generations backK020390 Modification to Fetal AssistHuntleigh Diagnostics, Ltd. · 2002
  3. 1 generation backK143114 Sense4Baby System Model B+ (MSA)Airstrip Technologies, Inc. · 2015 · Recalled
  4. This deviceK210025 INVU by NuvoNuvo- Group, Ltd. · 2021
  5. Descendant · cites it directly · 0 of its ownK221046 Invu by NuvoNuvo- Group, Ltd. · 2022

Most influential descendants

Showing 1 of 1 · See all
  • K221046Invu by NuvoNuvo- Group, Ltd. · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K002548Fetal AssistHuntleigh Diagnostics, Ltd.2001—
−2K020390Modification to Fetal AssistHuntleigh Diagnostics, Ltd.2002—
−1K143114Sense4Baby System Model B+ (MSA)Airstrip Technologies, Inc.20151
0 (this device)K210025INVU by NuvoNuvo- Group, Ltd.2021—
+1K221046Invu by NuvoNuvo- Group, Ltd.2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
FIG. 1 — Lineage of K210025, 2001–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LQK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LQK device

  1. #1 K253673 M•care System (MW-20)score 12.5 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K143114Sense4Baby System Model B+ (MSA)
Summary page 4
…ame: Home Uterine Activity Monitor Product Code: LQK Product Code Name: Home Uterine Activity Monitor Regulatory Class: II Predicate Device: Sense4Baby System Model B+ (K143114). The predicate device has been subject to a design-related recall (belt clip defects). Device Description INVU by Nuvo™ is a…
Airstrip Technologies, Inc.20151

Also cleared against K143114: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K221046Invu by NuvoNuvo- Group, Ltd.20220

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 6.2 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K221046 (Nuvo- Group, Ltd., 2022) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K143114.

How does its category compare?

All LQK devices

LQK Home Uterine Activity Monitor: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · LQK

1in 2022

2015: 12020: 12021: 12022: 12026 (partial year): 1
2007high 1 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LQK

Too few LQK 510(k)s in any year since 2007 to give a median.

Recalls per year · LQK

No recall names LQK since 2007.

Adverse event reports per year · LQK

No MAUDE report names LQK since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20151—00
20160—00
20170—00
20180—00
20190—00
20201—00
20211—00
20221—00
20230—00
20240—00
20250—00
20261—0—

What is it indicated for?

INVU by Nuvo™ is a maternal-fetal monitor that non-invasively measures and displays fetal heart rate (FHR), maternal heart rate (MHR) and Uterine Activity (UA). The INVU Sensor BandTM acquires the fetal heart electrocardiogram and maternal heart electrocardiogram signals from abdominal surface electrodes and the fetal phonocardiogram and the maternal phonocardiogram signals from surface acoustic sensors. The FHR, MHR and UA tracings are derived from…

Read the full statement (155 words)

INVU by Nuvo™ is a maternal-fetal monitor that non-invasively measures and displays fetal heart rate (FHR), maternal heart rate (MHR) and Uterine Activity (UA).

The INVU Sensor BandTM acquires the fetal heart electrocardiogram and maternal heart electrocardiogram signals from abdominal surface electrodes and the fetal phonocardiogram and the maternal phonocardiogram signals from surface acoustic sensors. The FHR, MHR and UA tracings are derived from these signals and presented.

INVU by Nuvo™ is indicated for use by pregnant women who are in their 32nd week of gestation (or later), with a singleton pregnancy.

The INVU by Nuvo™ maternal-fetal monitor is intended for use by healthcare professionals in health care facilities and by the patient in the patient’s home, on the order of a physician.

The INVU by Nuvo™ is indicated for antepartum fetal surveillance (i.e. non-stress testing).

This system does not prevent the onset of preterm labor nor will it prevent the occurrence of preterm birth.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K210025: INVU by Nuvo.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K210025

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026